Board of Directors

Ruoxi Chen - Principal, Warburg Pincus

Mr. Chen is a Principal at Warburg Pincus and joined the firm in 2011. Prior to Warburg Pincus, he worked as an Associate at the Carlyle Group in the U.S. Buyout Fund, and as an Analyst at Citigroup. Mr. Chen is a member of the Board of Directors of Silk Road Medical as well as Accriva Diagnostics, ComplexCare Solutions, Singular Bio, and Vertice Pharma. He received a B.S. magna cum laude in Economics and Computer Science from Duke University and an M.B.A. from Harvard Business School.

Tony Chou, MD - General Partner, The Vertical Group

Dr. Chou is a general partner at The Vertical Group, a healthcare focused venture capital firm. He co-founded Silk Road with Michi Garrison in 2007 and served as initial CEO. His career includes practicing as an interventional cardiologist and experience as a medical device industry executive. He previously had general management and business development responsibilities in the Abbott Vascular Division of Abbott Laboratories and last served as Division Vice President and General Manager of the vascular closure managing the FDA approval and global launch of the Perclose and Starclose products. Prior to joining Abbott, Dr. Chou was the Director of the Adult Cardiac Catheterization Laboratory at the University of California, San Francisco where he remains Associate Professor of Medicine. Dr. Chou received an MD from Case Western Reserve University and a BS in Physics and Electrical Engineering from Carnegie Mellon University.

In Seon Hwang - Managing Director, Warburg Pincus

In Seon Hwang is based in New York, joined Warburg Pincus in 2004 and leads the firm’s investment activities in the healthcare, consumer and retail sectors. Mr. Hwang is also a member of the firm’s Executive Management Group. Previously, he worked at GSC Partners, Goldman Sachs and the Boston Consulting Group. Mr. Hwang currently serves as a director of Glansaol, Outset Medical, Silk Road Medical and Specialists on Call. Mr. Hwang also serves on the External Advisory Board of the Institute for Translational Medicine and Therapeutics at the School of Medicine of the University of Pennsylvania and on the board of Hope for New York. Mr. Hwang received a B.S. in economics from the Wharton School of the University of Pennsylvania and an M.B.A. from Harvard Business School.

Jack W. Lasersohn - General Partner, The Vertical Group

Mr. Lasersohn has thirty years of experience in health care venture capital investments. Prior to joining The Vertical Group’s predecessor, F. Eberstadt in 1981 as a member of its venture capital division, Mr. Lasersohn was a corporate attorney with Cravath, Swaine & Moore. Mr. Lasersohn has served on the boards of over thirty medical companies and currently serves on the Boards of Directors of Anova, Masimo Corporation, Oncomed, and Silk Road Medical. He previously served on the boards of Bacchus Vascular, CardioThoracic Systems, Inc., Cardiovascular Imaging Systems, Inc., E.P. Technologies, Integrated Vascular Systems, Kyphon Inc, Metabolix and Proteolix . Mr. Lasersohn served on the Executive Committee of the Board of Directors of the National Venture Capital Association and is a past Chairman of the Medical Industry Group of the NVCA . He was the recipient of the NVCA’s Outstanding Service Award in 2008. In 2011, Mr. Lasersohn was appointed by the Office of the President to serve as an Entrepeneur in Residence at the FDA to develop an Innovation Pathway for medical devices. In 2012 he was appointed by the Secretary of HHS as a guest panel member of the Medicare Coverage and Advisory Committee (MEDCAC). He received a B.S. degree in Physics from Tufts University, an M.A. from The Fletcher School of Law and Diplomacy, and a J.D. from Yale Law School.

Richard W. Mott - Chairman of the Board, Principal, Walkabout Consulting LLC

Mr. Mott is currently a principal in Walkabout Consulting LLC, a management consulting and private equity firm. Mr. Mott served as President and Chief Executive Officer and Director of Kyphon Inc., a NASDAQ-listed global medical device company focused on minimally invasive spinal therapies, through its acquisition by Medtronic, Inc in late 2007. Prior to Kyphon, Mr. Mott held several executive positions at Wilson Greatbatch Technologies, Inc., most recently as Chief Operating Officer, as well as executive operating roles within the Bristol-Myers Squibb Company. Mr. Mott served as Chairman/Founder of Accendo, and Chairman of the Board of PhotoThera, Inc., both medical device companies investigating the use of light energy to treat various diseases and health conditions. Mr. Mott is the previous recipient of the Ernst & Young Entrepreneur of the Year Award and the Frost & Sullivan Technology Leadership of the Year Award. Mr. Mott holds a B.S. in Ceramic Engineering from Alfred University and is a Graduate of Harvard University’s Advanced Management Program.

Erica J. Rogers - President & CEO

Erica Rogers is the President and CEO of Silk Road Medical. Prior to Silk Road Medical, Erica was the COO of Medicines360, a non-profit pharmaceutical company developing drugs and devices for women. Erica was the founder and CEO of Allux Medical, as well as the co-founder of Visiogen, which was acquired by Abbott Medical Optics in 2009. Erica spent over 12 years at Boston Scientific, in sales and marketing positions. She began her career in pharmaceutical sales after receiving a B.S. in zoology from San Diego State University. Erica holds five issued and 15 pending US patents in medical devices and nanotechnology.

Bess Weatherman - Special Limited Partner, Warburg Pincus

Elizabeth H. Weatherman has served as a Director of Silk Road Medical since September 2011. Ms. Weatherman has held a position as Special Limited Partner of Warburg Pincus LLC, a global private equity firm focused on growth investing, since January 2016. Ms. Weatherman previously was a Managing Director of Warburg Pincus and a member of the firm’s Executive Management Group. She joined the firm Warburg Pincus in 1988 and primarily focused on the firm’s healthcare investment activities. Ms. Weatherman also serves on the board of directors of Wright Medical Group (NASDAQ: WMGI) and Accriva Diagnostics. Ms. Weatherman received a B.A. summa cum laude from Mount Holyoke College and holds an M.B.A. from the Stanford Graduate School of Business.

Special Advisor to the Board of Directors

Enrique Criado, MD

Vascular Surgeon Enrique Criado, M.D., serves as a Special Advisor to the Board of Directors of Silk Road Medical. Dr. Criado was a pioneer in developing the TransCarotid Artery Revascularization (TCAR) procedure and was involved in multiple rigorous clinical trials to evaluate the technique and patient outcomes, resulting in multiple peer-reviewed journal articles. Dr. Criado is the Chief of Vascular Surgery at MidMichigan Health and a member of MidMichigan’s comprehensive heart and vascular team. Before coming to MidMichigan, Dr. Criado practiced vascular surgery at the University of Michigan Cardiovascular Center where he served as a Professor of Vascular Surgery and Director of Endovascular Surgery. Prior to joining UMHS, Dr. Criado served as the Chief of Vascular Surgery at the State University of New York at Stony Brook, and Director of the Vascular Surgery Training Program, and previously served as Associate Professor of Surgery at the University of North Carolina at Chapel Hill, where he developed one of the first endovascular surgery programs in the USA. Dr. Criado is an experienced vascular and endovascular surgeon who has special expertise in endografting for abdominal and thoracic aortic aneurysms; complex cerebral vascular disease, including surgery of the vertebral artery; as well as treating renal and mesenteric disease. He is also accomplished in angioplasty, stenting, as well as the treatment of thoracic outlet syndrome and other complex vascular conditions.

  • ©2017 Silk Road Medical

  • 735 North Pastoria Avenue, Sunnyvale, CA 94085

    phone: 855.410.TCAR (8227)
    local phone: 408.720.9002
    fax: 408.720.9013